EMA plays a role in stimulating research and innovation in the pharmaceutical sector as part of its public health mandate.

This video summarizes the tools available at EMA throughout the different development phases and the different possibilities to interact with EMA. This includes the Innovation Task Force, qualification of novel methodologies, support to SMEs, orphan designation and ATMPS, as well as providing scientific advice and protocol assistance for orphans and priority medicines.